Home   >  
Protease/Metabolic Enzyme
  >  
HCV Protease

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

HCV Protease

Chemical Structure Cat. No. Product Name CAS No.
MK-4882 Chemical Structure
BCP13058 MK-4882 1246472-08-1
MK-4882 is a potent HCV NS5A inhibitor.
Elbasvir Chemical Structure
BCP29961 Elbasvir 1370468-36-2
Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.
Faldaprevir Chemical Structure
BCP27809 Faldaprevir 801283-95-4
Faldaprevir, also known as BI-201335, is a potent NS3/NS4A protease inhibitor potentially for the treatment of HCV infection.
Sovaprevir Chemical Structure
BCP28074 Sovaprevir 1001667-23-7
Sovaprevir is a nonstructural 3 (NS3) protease inhibitor potentially for the treatment of HCV infection
MK-5172 Chemical Structure
BCP28567 MK-5172 1350514-68-9
MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively.
Ombitasvir Chemical Structure
BCP28363 Ombitasvir 1258226-87-7
Ombitasvir is a potent inhibitor of the hepatitis C virus protein NS5A, with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5 and 366 pM against genotype 6a.
Ravidasvir dihydrochloride Chemical Structure
BCP20103 Ravidasvir dihydrochloride 1303533-81-4
Ravidasvir, also known as PPI-668 and ASC16, is a second-generation, orally active, potent and selective HCV NS5A protein inhibitor.
Ravidasvir Chemical Structure
BCP20102 Ravidasvir 1242087-93-9
Ravidasvir (PPI-668) is an investigational NS5A inhibitor in clinical trials for chronic hepatitis C genotype 4.
Ledipasvir (acetone) Chemical Structure
BCP24147 Ledipasvir (acetone) 1441674-54-9
Ledipasvir acetone is a hepatitis C virus (HCV) NS5A inhibitor.
MK8742 Chemical Structure
BCP09464 MK8742 1444832-51-2
Elbasvir(MK-8742) is a HCV NS5A inhibitor, which is currently in phase?2b clinical trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection.
123下一页末页共 35 条记录 1 / 4 页 
0086-13720134139